Home/Filings/4/0001209191-20-063298
4//SEC Filing

5AM Ventures V, L.P. 4

Accession 0001209191-20-063298

CIK 0001759138other

Filed

Dec 13, 7:00 PM ET

Accepted

Dec 14, 5:58 PM ET

Size

17.0 KB

Accession

0001209191-20-063298

Insider Transaction Report

Form 4
Period: 2020-12-10
Transactions
  • Sale

    Common Stock

    2020-12-10$14.75/sh36,916$544,511417,629 total(indirect: See footnotes)
  • Sale

    Common Stock

    2020-12-10$14.75/sh261,084$3,850,9892,953,634 total(indirect: See footnotes)
Transactions
  • Sale

    Common Stock

    2020-12-10$14.75/sh36,916$544,511417,629 total(indirect: See footnotes)
  • Sale

    Common Stock

    2020-12-10$14.75/sh261,084$3,850,9892,953,634 total(indirect: See footnotes)
PARMAR KUSH
10% Owner
Transactions
  • Sale

    Common Stock

    2020-12-10$14.75/sh261,084$3,850,9892,953,634 total(indirect: See footnotes)
  • Sale

    Common Stock

    2020-12-10$14.75/sh36,916$544,511417,629 total(indirect: See footnotes)
Transactions
  • Sale

    Common Stock

    2020-12-10$14.75/sh36,916$544,511417,629 total(indirect: See footnotes)
  • Sale

    Common Stock

    2020-12-10$14.75/sh261,084$3,850,9892,953,634 total(indirect: See footnotes)
Transactions
  • Sale

    Common Stock

    2020-12-10$14.75/sh261,084$3,850,9892,953,634 total(indirect: See footnotes)
  • Sale

    Common Stock

    2020-12-10$14.75/sh36,916$544,511417,629 total(indirect: See footnotes)
Transactions
  • Sale

    Common Stock

    2020-12-10$14.75/sh261,084$3,850,9892,953,634 total(indirect: See footnotes)
  • Sale

    Common Stock

    2020-12-10$14.75/sh36,916$544,511417,629 total(indirect: See footnotes)
Transactions
  • Sale

    Common Stock

    2020-12-10$14.75/sh261,084$3,850,9892,953,634 total(indirect: See footnotes)
  • Sale

    Common Stock

    2020-12-10$14.75/sh36,916$544,511417,629 total(indirect: See footnotes)
Footnotes (4)
  • [F1]Shares are held directly by 5AM Ventures V, L.P. ("5AM V").
  • [F2]5AM Partners V, LLC ("5AM Partners") is the sole general partner of 5AM V. Dr. Kush Parmar, Andrew J. Schwab and Dr. Scott M. Rocklage are managing members of 5AM Partners and may be deemed to have shared voting and investment power over the shares beneficially owned by 5AM V. Each of 5AM Partners, Dr. Parmar, Mr. Schwab and Dr. Rocklage disclaims beneficial ownership of the shares of Preferred Stock held directly by 5AM V, except to the extent of its or his pecuniary interest therein.
  • [F3]Shares are held directly by 5AM Opportunities I, L.P. ("Opportunities").
  • [F4]5AM Opportunities I (GP), LLC ("Opportunities GP") is the sole general partner of Opportunities. Andrew J. Schwab and Dr. Kush Parmar are managing members of Opportunities GP and may be deemed to have shared voting and investment power over the shares beneficially owned by Opportunities. Each of Opportunities GP, Mr. Schwab and Dr. Parmar disclaims beneficial ownership of the shares of Common Stock held directly by Opportunities, except to the extent of its or his pecuniary interest therein.

Issuer

Cabaletta Bio, Inc.

CIK 0001759138

Entity typeother
IncorporatedDE

Related Parties

1
  • filerCIK 0001674324

Filing Metadata

Form type
4
Filed
Dec 13, 7:00 PM ET
Accepted
Dec 14, 5:58 PM ET
Size
17.0 KB